Using a Dynamic Model to Consider Optimal Antiviral Stockpile Size in the Face of Pandemic Influenza Uncertainty

PLoS ONE

Volumn 8, Issue 6, 2013, Pages

  Greer, Amy L ^a,b   Schanzer, Dena ^a  

^a PUBLIC HEALTH AGENCY OF CANADA   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIVIRUS AGENT; INFLUENZA VACCINE;

ADOLESCENT; ADULT; AGED; ANTIVIRAL THERAPY; ARTICLE; CANADA; CHILD; DISEASE SEVERITY; DISEASE TRANSMISSION; FLU LIKE SYNDROME; HEALTH CARE NEED; HEALTH CARE PLANNING; HUMAN; INFANT; MATHEMATICAL MODEL; NATIONAL ANTIVIRAL STOCKPILE SIZE; PANDEMIC INFLUENZA; POPULATION RESEARCH; PREVALENCE; RESPIRATORY TRACT INFECTION; SCHOOL CHILD; SEASONAL VARIATION; SPRING; SUMMER; UNCERTAINTY; INFLUENZA A VIRUS; INFLUENZA, HUMAN; PANDEMIC; THEORETICAL MODEL;

ANTIVIRAL AGENTS; CANADA; HUMANS; INFLUENZA A VIRUS; INFLUENZA, HUMAN; MODELS, THEORETICAL; PANDEMICS; STRATEGIC STOCKPILE;

EID: 84879272128     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0067253     Document Type: Article

References (61)

1. Johnson N, Mueller J, (2002) Updating the accounts: global mortality of the 1918-1920 "Spanish" influenza pandemic. Bulletin of the History of Medicine 76: 105-115.
2. Azziz-Baumgartner E, Smith N, Gonzalez-Alvarez R, Daves S, Layton M, et al. (2009) National pandemic influenza preparedness planning. Influenza and Other Respiratory Viruses 3: 189-196.
3. Tam T, Sciberras J, Mullington B, King A, (2005) Fortune favours the prepared mind- A national perspective on pandemic preparedness. Canadian Journal of Public Health-Revue Canadienne De Sante Publique 96: 406-408.
4. Webster P, (2004) Canada strengthens pandemic plan in wake of SARS. Lancet 363: 628-628.
5. Zhang XZ, Meltzer MI, Wortley PM, (2006) FluSurge- A tool to estimate demand for hospital services during the next pandemic influenza. Medical Decision Making 26: 617-623.
6. The Public Health Agency of Canada (2006) The Canadian Pandemic Influenza Plan for the Health Sector. Ottawa, ON: Government of Canada.
7. Glass K, Becker NG, (2009) Estimating antiviral effectiveness against pandemic influenza using household data. Journal of the Royal Society Interface 6: 695-703.
8. Lee S, Chowell G, Castillo-Chavez C, (2010) Optimal control for pandemic influenza: The role of limited antiviral treatment and isolation. Journal of Theoretical Biology 265: 136-150.
9. Longini IM, Halloran ME, Nizam A, Yang Y, (2004) Containing pandemic influenza with antiviral agents. American Journal of Epidemiology 159: 623-633.
10. McVernon J, McCaw JM, Nolan TM, (2010) Modelling strategic use of the national antiviral stockpile during the CONTAIN and SUSTAIN phases of an Australian pandemic influenza response. Australian and New Zealand Journal of Public Health 34: 113-119.
11. Moghadas SM, Bowman CS, Rost G, Fisman DN, Wu JH (2009) Post-exposure prophylaxis during pandemic outbreaks. BMC Medicine 7.
12. Nuno M, Chowell G, Gumel AB, (2007) Assessing the role of basic control measures, antivirals and vaccine in curtailing pandemic influenza: scenarios for the US, UK and the Netherlands. Journal of the Royal Society Interface 4: 505-521.
13. Potter CW, (2001) A history of influenza. Journal of Applied Microbiology 91: 572-579.
14. Schanzer DL, McGeer A, Morris K (2012) Statistical estimates of respiratory admissions attributable to seasonal and pandemic influenza for Canada. Influenza and Other Respiratory Viruses.
15. Becker NG, Wang D, (2011) Can antiviral drugs contain pandemic influenza transmission? PloS ONE 6: e17764.
16. Carrasco LR, Lee VJ, Chen MI, Matchar DB, Thompson JP, et al. (2011) Strategies for antiviral stockpiling for future influenza pandemics: a global epidemic-economic perspective. Journal of the Royal Society Interface: 1-7.
17. Dimitrov NB, Goll S, Hupert N, Pourbohloul B, Meyers LA, (2011) Optimizing tactics for use of the U.S. antiviral strategic national stockpile for pandemic influenza. PLOS ONE 6: e16094-e16094.
18. Kelso JK, Halder N, Milne GJ (2010) The Impact of Case Diagnosis Coverage and Diagnosis Delays on the Effectiveness of Antiviral Strategies in Mitigating Pandemic Influenza A/H1N1 2009. PLOS ONE 5.
19. Moss R, McCaw JM, McVernon J (2011) Diagnosis and Antiviral Intervention Strategies for Mitigating an Influenza Epidemic. PLOS ONE 6.
20. Skowronski DM, Janjua NZ, De Serres G, Hottes TS, Dickinson JA, et al. (2011) Effectiveness of AS03 adjuvanted pandemic H1N1 vaccine: case-control evaluation based on sentinel surveillance system in Canada, autumn 2009. British Medical Journal 342: c7297.
21. Biggerstaff M, Kamimoto L, Finelli L, Balluz L, (2011) Self-reported influenza-like illness during the 2009 H1N1 influenza pandemic-United States, September 2009- March 2010. Morbidity and Mortality Weekly Report 60: 37-41.
22. Tsalik E, Hendershot E, Sangvai D, Cunningham H, Cunningham C, et al. (2010) Clinical presentation and response to treatment of novel influenza A H1N1 in a university-based summer camp population. Journal of Clinical Virology 47: 286-288.
23. Siddiqui MR, Edmunds WJ, (2008) Cost-effectiveness of antiviral stockpiling and near-patient testing for potential influenza pandemic. Emerging Infectious Diseases 14: 267-274.
24. Friedman MJ, Attia MW, (2004) Clinical predictors of influenza in children. Archives of Pediatrics & Adolescent Medicine 158: 391-394.
25. Monto AS, Gravenstein S, Elliott M, Colopy M, Schweinle J, (2000) Clinical signs and symptoms predicting influenza infection. Archives of Internal Medicine 160: 3243-3247.
26. Ohmit SE, Monto AS, (2006) Symptomatic predictors of influenza virus positivity in children during the influenza season. Clinical Infectious Diseases 43: 564-568.
27. Socan M, Prosenc K, Nagode M, (2010) Differences in clinical predictors of influenza in adults and children with influenza-like illness. Central European Journal of Medicine 5: 41-48.
28. Thursky K, Cordova SP, Smith D, Kelly H, (2003) Working towards a simple case definition for influenza surveillance. Journal of Clinical Virology 27: 170-179.
29. Tuite A, Kwong J, Fisman D, Greer A, (2010) Optimal Pandemic Influenza Vaccine Allocation Strategies for the Canadian Population. PLoS ONE 5: 1-11.
30. Vynnycky E, Edmunds WJ, (2008) Analyses of the 1957 (Asian) influenza pandemic in the United Kingdom and the impact of school closures. Epidemiology and Infection 136: 166-179.
31. Fraser C, Riley S, Anderson RM, Ferguson NM, (2004) Factors that make an infectious disease outbreak controllable. PNAS 101: 6146-6151.
32. Statistics Canada (2007) Age and Sex Highlight Tables, 2006 Census. Available: http://www12.statcan.gc.ca/census-recens?ement/2006/dp-pd/hlt/97-551/index.cfm?La?ng = E. Accessed 2009 Aug 21.
33. Mossong J, Hens N, Jit M, Beutels P, Auranen K, et al. (2008) Social contacts and mixing patterns relevant to the spread of infectious diseases. Plos Medicine 5: 381-391.
34. Statistics Canada (2007) Canadian Community Health Survey (CCHS)- Detailed information for 2007 (Cycle 4.1). Available: http://www.statcan.gc.ca/cgi-bin/imdb/p2SV.plFunction=getSurvey&SurvId=3226&SurvVer=1&SDDS=3226&InstaId=15282&InstaVer=4&lang= n&db=imdb&adm=8&dis=2. Accessed 2009 Aug 2009.
35. Statistics Canada (2009) Pregnancy outcomes by age group (live births). Available: http://www40.statcan.gc.ca/l01/cst01/hlt?h65b-eng.htm. Accessed 2009 Aug 21.
36. Statistics Canada (2009) Pregnancy outcomes by age group (total pregnancies). Available: http://www40.statcan.gc.ca/l01/cst01/hlt?h65a-eng.htm. Accessed 2009 Aug 21.
37. Tuite AR, Greer AL, Whelan M, Winter A-L, Lee B, et al. (2009) Estimated epidemiologic parameters and morbidity associated with pandemic H1N1 influenza. CMAJ 182: 131-136.
38. Chowell G, Ammon CE, Hengartner NW, Hyman JM, (2006) Transmission dynamics of the great influenza pandemic of 1918 in Geneva, Switzerland: Assessing the effects of hypothetical interventions. Journal of Theoretical Biology 241: 193-204.
39. Gani R, Hughes H, Fleming D, Griffin T, Medlock J, et al. (2005) Potential impact of antiviral drug use during influenza pandemic. Emerging Infectious Diseases 11: 1355-1362.
40. Hall IM, Gani R, Hughes HE, Leach S, (2007) Real-time epidemic forecasting for pandemic influenza. Epidemiology and Infection 135: 372-385.
41. Mills CE, Robins JM, Lipsitch M, (2004) Transmissibility of 1918 pandemic influenza. Nature 432: 904-906.
42. Viboud C, Tam T, Fleming D, Handel A, Miller MA, et al. (2006) Transmissibility and mortality impact of epidemic and pandemic influenza, with emphasis on the unusually deadly 1951 epidemic. Vaccine 24: 6701-6707.
43. Cooper BS, Pitman RJ, Edmunds WJ, Gay NJ, (2006) Delaying the international spread of pandemic influenza. PLoS Medicine 3: 845-855.
44. Longini IM, Seaholm SK, Ackerman E, Koopman JS, Monto AS, (1984) Simulation studies of influenza epidemics- assessment of parameter- estimation and sensitivity International Journal of Epidemiology. 13: 496-501.
45. Tuite A, Fisman D, Kwong J, Greer A (2009) Seasonal vaccine allocation in the Canadian population during a pandemic. PLoS Currents: Influenza.
46. Schanzer D, Langley J, Dummer T, Viboud C, Tam T, (2010) A Composite Epidemic Curve for Seasonal Influenza in Canada with an International Comparison. Influenza and Other Respiratory Viruses 4: 295-306.
47. Shaman J, Goldstein E, Lipsitch M, (2011) Absolute Humidity and Pandemic Versus Epidemic Influenza. American Journal of Epidemiology 173: 127-135.
48. Shaman J, Pitzer VE, Viboud C, Grenfell BT, Lipsitch M (2010) Absolute Humidity and the Seasonal Onset of Influenza in the Continental United States. PLoS Biology 8.
49. Bjornstad ON, Finkenstadt BF, Grenfell BT, (2002) Dynamics of measles epidemics: Estimating scaling of transmission rates using a Time series SIR model. Ecological Monographs 72: 169-184.
50. Dushoff J, Plotkin JB, Levin SA, Earn DJD, (2004) Dynamical resonance can account for seasonality of influenza epidemics. Proceedings of the National Academy of Sciences of the United States of America 101: 16915-16916.
51. Lofgren E, Fefferman N, Naumov Y, Gorski J, Naumova E, (2007) Influenza Seasonality: Underlying Causes and Modeling Theories. Journal of Virology 81: 5429-5436.
52. Glezen WP (2011) Cell-culture-derived influenza vaccine production. The Lancet.
53. D'Aoust M-A, Lavoie P-O, Couture MM-J, Trepanier S, Guay J-M, et al. (2008) Influenza virus-like particles produces by transient expression in Nicotiana bentamiana induce a protective immune response against a lethal viral challenge in mice. Plant Biotechnolocy Journal 6: 930-940.
54. Aoki FY, Allen UD, Stiver HG, Evans GA, (2010) The use of antiviral drugs for influenza: Guidance for practitioners. 2010-2011: 1-49.
55. Monto A, (1994) Studies of the community and family: acute respiratory illness and infection. Epidemiological Review 16: 351-373.
56. Public Health Agency of Canada (2008) FluWatch Reports. Available: http://www.phac-aspc.gc.ca/fluwatch/09-10/w42_09/index-eng.php Accessed: 2009 Nov 5.
57. Schanzer D, Langley J, Tam T, (2008) Role of influenza and other respiratory viruses in admissions of adults to Canadian hospitals. Influenza and Other Respiratory Viruses 2: 1-8.
58. Schanzer D, Zheng H, Gilmore J (2011) Statistical Estimates of Absenteeism Attributable to Influenza from the Labour Force Survey. BMC Infectious Diseases: 1-9.
59. Kwong JC, Stukel TA, Lim J, McGeer AJ, Upshur REG, et al. (2008) The Effect of Universal Influenza Immunization on Mortality and Health Care Use. Plos Medicine 5: 1440-1452.
60. Moran K, Maaten S, Guttmann A, Northrup D, Kwong JC, (2009) Influenza vaccination rates in Ontario children: Implications for universal childhood vaccination policy. Vaccine 27: 2350-2355.
61. Monto A, (2002) Epidemiology of Viral Respiratory Infections. The American Journal of Medicine 112: 4S-12S.